πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 49 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12161621

Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease

The Regents of the University of Colorado Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11896603

Oligosaccharide as therapeutic agent for alcohol associated liver disease

The Regents of the University of California Β· Granted Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11547736

Sauvignon blanc grape seed products for nonalcoholic fatty liver disease

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11528924

Alcoholic beverage substitutes

CLEARMIND MEDICINE INC. Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11484523

Compositions for prevention and treatment of symptoms associated with alcohol consumption

Purple Biosciences LLC Β· Granted Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11439635

B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoho

Northwestern University Β· Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11400052

Alcohol-resistant drug formulations

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11400072

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11357777

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

Cyclerion Therapeutics, Inc. Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11298317

Alcoholic compositions having a lowered risk of acetaldehydemia

Deuteria Beverages, LLC Β· Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11179384

Treatment of nonalcoholic fatty liver disease

TAKEDA GMBH Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11135309

Poly(vinyl alcohol) nanocarriers

The Regents of the University of California Β· Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10941248

Methods for preparing functionalized polymers from polymer alcohols

Nektar Therapeutics Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894073

Pinot noir grape products for nonalcoholic fatty liver disease and other uses

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10772865

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. Β· Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10731116

Alcoholic compositions having a lowered risk of acetaldehydemia

Deuteria Beverages, LLC Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10555929

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537528

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

The Regents of the University of California Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10357460

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS Β· Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10307386

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

The Regents of the University of California Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10258576

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS Β· Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10144804

Method for preparing functionalized polymers from polymer alcohols

Nektar Therapeutics Β· Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10130671

Chardonnay grape seed products for nonalcoholic fatty liver disease

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10047330

Alcoholic compositions having a lowered risk of acetaldehydemia

Deuterla Beverages, LLC Β· Granted Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted